# Indonesia stem cell therapy regulation

> Live situation record from CLSTR: https://clstr.news/situations/indonesia-stem-cell-therapy-regulation
> Updated: 2026-08-29T07:31:35.000Z. Sources: 4. Developments: 2.

The Indonesian government is moving to regulate and standardize stem cell and regenerative therapies. Initially, the Indonesian Food and Drug Authority (BPOM) issued a warning against unregulated clinics, noting that violators distributing products that fail to meet safety standards could face up to 12 years in prison and significant fines.

Following these warnings, the Ministry of Health has begun promoting the development of stem cell therapy as a safe, evidence-based medical service. The Ministry is focusing on ensuring therapies are administered by competent personnel and sourced from licensed, traceable laboratories. Efforts are underway to strengthen the regenerative medicine ecosystem through improved research hospital capabilities, laboratory capacity, and patient outcome monitoring.

## Timeline

### 2026-08-29: Indonesia promotes safe, evidence-based stem cell therapy

Indonesia's Health Ministry is pushing for regulated, evidence-based stem cell therapy to ensure patient safety and clinical efficacy in regenerative medicine.

2 sources. https://clstr.news/cluster/indonesia-promotes-safe-evidence-based-stem-cell-therapy

### 2026-08-26: BPOM warns of prison terms for unregulated stem cell therapies

Indonesia's BPOM warns that clinics offering substandard stem cell therapies face up to 12 years in prison and 5 billion rupiah in fines per item.

2 sources. https://clstr.news/cluster/bpom-warns-of-prison-terms-for-unregulated-stem-cell-therapies

---
Cite as: Indonesia stem cell therapy regulation. CLSTR, https://clstr.news/situations/indonesia-stem-cell-therapy-regulation